PDS Biotechnology Corp
PDSB· Nasdaq
Filed Mar 1, 2018 · 10-K · 60 days after period end · 0001140361-18-011218
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Net Income | -$13.91M | -$9.52M | -$7.96M | -$3.16M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 1, 2018 · 60 d after period end